Vanguard PRIMECAP (VPMCX) Review
As a Vanguard PRIMECAP (VPMCX) review, investigation into the makeup and performance of this stock was done. At present this fund is closed to new investors.
The main aspect of this fund is to look for capital appreciation on a long term. The types of stocks this fund holds are large to medium size American companies that could be high performers that have not been noticed by other investors, so their stocks are low and at a good value. A key indicator that this fund will like a company is a strong leadership that is actively involved in the management of the firm.
As of 9/30/09 this stock was at %55.10. This is a high risk, high return valued stock. There are 112 different stocks that are being held by this fund with the 10 largest stocks making up 33.0% of the overall holdings. The total net assets of the fund are $26.2 billion.
The top ten stocks held by this fund are Amgen Inc., FedEx corp., Eli Lily & Co., Oracle Corp., Novartis AG ADR, Medtronic, Inc., Google Inc., Adobe systems Inc., Texas Instruments Inc. and Microsoft Corp.
This fund was founded in 1983 and has a return before taxes of 13.18% since that time. It performance in the past 5 years has been 4.51% return. This past year was not so good, but no stock was. This past year return before taxes was at -4.01%
The 52 week low of the stock price was $35.36 and the high was at $62.08.
This Vanguard PRIMECAP (VPMCX) review is positive. As a best vanguard funds go, this one lost less than most in the recent recession.